TGA
Oral opioid shortages to continue
Shortages of Oxynorm capsules and Ordine oral liquid are expected to last until late 2024, the TGA reports Manufacturers of two oral opioid products are forecasting that shortages of some …
Profession needs vape guidelines
TGA urged to review vapes and produce guidelines to allay pharmacists’ concerns about stocking products The Therapeutic Goods Administration (TGA) needs to review the safety, efficacy and performance of vaping …
New criminal offences and civil penalties on vapes: TGA
The TGA has issued a statement about the changes to vaping which will take effect on from July 2024 “The new legislation introduces a single, consistent framework that applies nationally …
TGA takes RAT action
Federal Court proceedings have been initiated over the alleged importation and supply of unapproved Covid-19 RATs Queensland-based company, Key Promotional Products Pty Ltd (KPP) and the husband of the firm’s …
Vyvanse shortages return
Less than two months after the TGA declared shortages of Vyvanse to be “resolved” the regulator is now reporting the medication is once again in short supply The Therapeutic Goods …
Suspended sentence for Therapeutic Goods Act breaches
Business owner handed a two-year suspended sentence for his role in the unlawful manufacture, supply and export of performance and image-enhancing drugs Businessman, Ryan Gregory McTeigue, has avoided time behind …
Zactin Tabs shortage set to continue
TGA extends fluoxetine substitution instrument in response to ongoing manufacturing issues Supply shortages impacting Zactin Tabs (fluoxetine 20mg dispersible tablets) are expected to continue until 30 June 2024, the medication’s …
Pharmacy fined over Ozempic advertising
Western Sydney pharmacy hit with a fine of more than $18,000 in relation to alleged unlawful advertising of Ozempic The Therapeutic Goods Administration (TGA) has issued an infringement notice of $18,780 …
No change to paracetamol
TGA rules out a general sale option for small effervescent, child resistant, paracetamol packs The Therapeutic Goods Administration (TGA) has confirmed a preliminary decision to reject a proposal to allow …
New sexual dysfunction warnings added to antidepressants’ PI
Health professionals are advised to consider current or previous antidepressant use in patients reporting sexual dysfunction Updated product information documents (PIs) for nine antidepressant medications will include warnings relating to …
TGA continues cannabis advertising clampdown
Regulator targets medicinal cannabis pharmacy over alleged unlawful advertising The Therapeutic Goods Administration (TGA) has issued nine infringement notices totalling $164,460 to Victorian pharmacy, Better Leaf Pty Ltd, over alleged unlawful …
Government acts on compounding concerns
Compounding exemptions for diabetes medications, Ozempic and Mounjaro, will be removed from 1 October, minister reveals Compounding pharmacies will be barred from producing replicas of Ozempic (semaglutide) and Mounjaro (tirazapetide) …